Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Daljeet Kohli Reveals His Model Portfolio Of Top 10 Stocks



Daljeet Kohli has put the spotlight on ten top-quality stocks which he says ought to be bought now post Q4FY15 results




If you have a stock query, you can ask at the Stocks Talk Forum!. Some knowledgeable investors may have an answer

Daljeet, as is his custom, has made a careful selection of stocks while preparing the Model Portfolio. First he has taken care to ensure that all the top sectors such as Pharma, Financials, FMCG, Power etc find place in the portfolio. Then, he has ensured that there is an equitable distribution amongst the large-caps and mid-caps. This strategy ensures that the portfolio remains stable even in the midst of heavy turbulence.

A detailed rationale in support of each stock is also given in the note.

Click here to download IndiaNivesh’s Model Portfolio of top 10 stocks
investments, Large Cap, Mid Cap, Multibagger, Portfolio, Stock Picks    , , , , ,

1 Comment
  1. .pd..'s Gravatar .pd..
    June 9, 2015 at 5:19 pm | Permalink

    no meghmani org ???

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 493 other subscribers

RSS Stocks Talk Forum

  • Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap)
    Top Picks Basket of 16 Stocks (8 Large-Cap, 5 Mid-Cap & 3 Small-Cap) for Nov '24. The Basket has delivered return of 329% since inception (May’20) vs 162% return delivered by NIFTY Index over the same period due to thematic approach to Top Picks selection Download report
  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!